RXRX · Recursion Pharmaceuticals, Inc.
SELL 87%
153
Total trades
17
Insiders on record
87%
Avg confidence
SELL
Signal direction
Recent insider trades
| Date | Insider | Action | Type | Value | Confidence |
|---|---|---|---|---|---|
| Apr 7, 2026 | Blake Borgeson | SELL | Open-market sale | 93K | 0.95 |
| Mar 23, 2026 | Christopher Gibson | SELL | Open-market sale | 130K | 0.93 |
| Mar 17, 2026 | Ben R Taylor | SELL | Open-market sale | 27K | 0.91 |
| Mar 9, 2026 | Najat Khan | SELL | Open-market sale | 94.7K | 0.98 |
| Mar 3, 2026 | Blake Borgeson | SELL | Open-market sale | 588.2K | 0.88 |
| Feb 19, 2026 | Christopher Gibson | SELL | Open-market sale | 138.4K | 0.93 |
| Feb 18, 2026 | Ben R Taylor | SELL | Open-market sale | 41.4K | 0.91 |
| Feb 4, 2026 | Christopher Gibson | SELL | Open-market sale | 164.8K | 0.93 |
| Feb 3, 2026 | Blake Borgeson | SELL | Open-market sale | 924K | 0.88 |
| Jan 20, 2026 | Christopher Gibson | SELL | Open-market sale | 178.8K | 0.93 |
Recursion Pharmaceuticals, Inc. has 153 total insider trades on record. Sign up to see the full history, track records, and evidence trails.
Want alerts when insiders trade RXRX?
Sign up free to get notified, see the full trade history, and track insider conviction over time.
Sign up freeInsiderTrack aggregates publicly available SEC Form 4 filings. Data is provided for informational purposes only and should not be construed as investment advice. Always do your own research before making investment decisions.